Back to ALLIANCEBERNSTEIN L.P. ALLIANCEBERNSTEIN L.P.

NAMSNAMS
7 quarters

Position history for ALLIANCEBERNSTEIN L.P.ALLIANCEBERNSTEIN L.P.'s holdings in NEWAMSTERDAM PHARMA COMPANY

ALLIANCEBERNSTEIN L.P. holds 1.3M shares of NAMS (NEWAMSTERDAM PHARMA COMPANY), worth $40.3M as of 2026-Q2. The position was increased (+5.0% shares). NAMS represents 0.0% of ALLIANCEBERNSTEIN L.P.'s portfolio.

Current Value

$40.3M

Current Shares

1.3M

Total Value Change

-$7.4M

Total Shares Change

-598,125

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.3M
+5.0%
$40.3M0.0%$33.89
31
2026-Q1
Decreased
1.2M
-7.8%
$42.1M0.0%$30.41
0
2025-Q4
Decreased
1.3M
-39.3%
$45.6M0.0%$34.74
0
2025-Q3
Decreased
2.1M
-8.1%
$60.9M0.0%$27.52
0
2025-Q2
Increased
2.3M
+4.0%
$42.2M0.0%$18.57
30
2025-Q1
Increased
2.2M
+20.7%
$45.9M0.0%$21.76
35
2024-Q4
New
1.9M
-
$47.8M0.0%$25.60
40

Other major holders of NAMS: Capital World Investors, FMR LLC, RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used